Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARMC2 antisense RNA 1 (ARMC2-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 6. It is classified as an antisense transcript, meaning it is transcribed from the DNA strand opposite to the protein-coding ARMC2 gene. ARMC2-AS1 is a member of the lncRNA family and its function remains largely uncharacterized; there is currently no evidence that it encodes a protein or that it acts as a direct therapeutic target. Some disease associations, notably with male infertility phenotypes such as teratozoospermia and spermatogenic failure 38, are reported, but the specific mechanism linking ARMC2-AS1 to these conditions is not established. There are no drugs, biomarkers, or safety concerns directly associated with this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARMC2 antisense RNA 1 (ARMC2-AS1).